nad has been researched along with beta-acetyldigoxin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galenko-Yaroshevskii, PA; Kanorskii, SG; Zingilevskii, KB | 1 |
| Dzhanashiya, PKh; Salibegashvili, NV; Vladytskaya, OV | 1 |
| Gongadze, NV; Sukoyan, GV | 1 |
2 trial(s) available for nad and beta-acetyldigoxin
| Article | Year |
|---|---|
Efficiency of refracterin in patients with chronic cardiac insufficiency caused by coronary heart disease.
Topics: Acetyldigoxins; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Coronary Disease; Cytochromes c; Drug Combinations; Echocardiography; Female; Humans; Inosine; Male; Middle Aged; NAD; Oxyfedrine; Systole; Treatment Outcome; Ventricular Function, Left | 2004 |
Efficiency and mechanisms of the antioxidant effect of standard therapy and refracterin in the treatment of chronic heart failure in elderly patients with postinfarction cardiosclerosis.
Topics: Acetyldigoxins; Aged; Aged, 80 and over; Antioxidants; Cardiotonic Agents; Cytochromes c; Drug Combinations; Heart Failure; Humans; Inosine; Myocardial Infarction; NAD; Oxidative Stress; Oxyfedrine; Sclerosis | 2004 |
1 other study(ies) available for nad and beta-acetyldigoxin
| Article | Year |
|---|---|
Mechanism of cardioprotective effect of adenocine and non-glycoside cardiotonic drugs during experimental chronic cardiac insufficiency.
Topics: Acetyldigoxins; Adenosine; Adenosine Triphosphate; Animals; Apoptosis; Cardiotonic Agents; Constriction, Pathologic; Female; Heart; Heart Failure; Heart Ventricles; Hydrazones; Male; Milrinone; Myocardium; Myocytes, Cardiac; NAD; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Pyridazines; Rabbits; Reperfusion; Simendan; Ventricular Function | 2011 |